Description
YONDELIS (trabectedin) is a prescription intravenous alkylating drug used in cancer treatment. It's manufactured by Janssen Products, LP as a lyophilized powder for injection, with each vial containing 1 mg of trabectedin. Approved under NDA207953, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Trabectedin | HTML | Access the FDA dataset for Trabectedin — ANDA 207953 submitted by Mylan Institutional LLC | Open resource |